Company Analysis

OPKO Health, Inc. (OPK)

Nasdaq: OPK · Pharmaceutical Preparations · Miami, FL · filing with the SEC since 1996
Grade5.2
◀ Past 5.3● Present 6.2▶ Future 3.9
1 est.

Who runs OPKO Health, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Paganelli John A
Interim CEO, COB. First filing Jan 2006, latest Nov 5, 2026, 5 filings in all.
Officers reporting now
6
of 10 people with a filing in the last fifteen months
Directors reporting now
4
23 people on the record since 2006
Officerssales are open-market, Nov 5, 2025 to Nov 5, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Paganelli John AInterim CEO, COBJan 2006Nov 5, 20262 · $0.00
Logal AdamSr. Vice President, CFOApr 2007Jul 28, 2026none
Rubin Steven DExecutive VP-AdministrationFeb 2007Jul 28, 2026none
Uppaluri Subbarao VSr Vice President - CFOFeb 2007Jun 22, 2026none
Frost Gamma Investments TrustCEO & ChairmanFeb 2007Nov 21, 2025none
Frost Phillip Md Et AlCEO & ChairmanFeb 2007Nov 21, 2025none
Directorssales are open-market, Nov 5, 2025 to Nov 5, 2026
NameRoleFirst filingLatest filingSales, 12 months
Lachman Prem AdirectorMar 2021Jun 22, 2026none
Medel Roger MddirectorDec 2020Jun 22, 2026none
Pfenniger Richard C JrdirectorJan 2008Jun 22, 2026none
Yu Alice Lin-TsingdirectorApr 2009Jun 22, 2026none
Earlier names on the record14, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton OPK · research, not advice